Citation

Interian A, Chesin M, Kline A, Miller R, Hill LS, Latorre M, Shcherbakov A, King A, Stanley B. Arch. Suicide Res. 2018; 22(2): 278-294.

Affiliation

Molecular Imaging and Neuropathology Division , New York State Psychiatric Institute , New York , NY.

Copyright

(Copyright © 2018, International Academy of Suicide Research, Publisher Informa - Taylor and Francis Group)

DOI

10.1080/13811118.2017.1334610

PMID

28598723

Abstract

Efforts to better understand and prevent suicide have increasingly pointed to the prospective assessment of suicidal behaviors in clinical trials. These assessments are aided by instruments such as the Columbia-Suicide Severity Rating Scale (C-SSRS), which have sought to improve the conceptual uniformity and ease by which suicidal behaviors are classified. At the same time, assessment and classification of suicidal behaviors has been a longtime challenge in the field. To aide users of the C-SSRS, this manuscript illustrates the use of the C-SSRS in instances where classification complexities arise. Illustrations are presented based on cases encountered during a clinical trial for a suicide prevention intervention. Key decision points are summarized and classification issues that warrant consideration for future refinement of such decisions are discussed.

Language: en

Keywords

assessment; classification; suicidal behavior